Tags

Type your tag names separated by a space and hit enter

A critical literature review of health economic evaluations in pertussis booster vaccination.
Expert Rev Pharmacoecon Outcomes Res. 2012 Feb; 12(1):71-94.ER

Abstract

A review of worldwide economic evaluations of pertussis booster vaccination for adolescents and adults was conducted. Thirteen cost-effectiveness, cost-utility and economic impact models were identified. The most frequently studied strategies were adolescent booster, one-time adult booster, adult decennial boosters and cocoon strategy. All studies evaluating adolescent booster suggested this was a cost-effective or cost-saving strategy compared with no booster vaccination. Conclusions concerning adult vaccination, alone or in combination with adolescent vaccination, vary between studies. Studies were often strongly affected by assumptions regarding the amount of unreported cases and lack of reliable input data on real incidence, other epidemiological inputs, costs associated with mild disease and herd immunity effects. Reviewed studies were generally in favor of pertussis booster vaccination, but did not identify any optimal vaccination strategy. Future economic evaluations should explore a wider range of strategies, taking into account country-specific considerations.

Authors+Show Affiliations

Creativ-Ceutical, 215 rue du Faubourg Saint Honoré, 75008 Paris, France.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

22280198

Citation

Millier, Aurelie, et al. "A Critical Literature Review of Health Economic Evaluations in Pertussis Booster Vaccination." Expert Review of Pharmacoeconomics & Outcomes Research, vol. 12, no. 1, 2012, pp. 71-94.
Millier A, Aballea S, Annemans L, et al. A critical literature review of health economic evaluations in pertussis booster vaccination. Expert Rev Pharmacoecon Outcomes Res. 2012;12(1):71-94.
Millier, A., Aballea, S., Annemans, L., Toumi, M., & Quilici, S. (2012). A critical literature review of health economic evaluations in pertussis booster vaccination. Expert Review of Pharmacoeconomics & Outcomes Research, 12(1), 71-94. https://doi.org/10.1586/erp.11.94
Millier A, et al. A Critical Literature Review of Health Economic Evaluations in Pertussis Booster Vaccination. Expert Rev Pharmacoecon Outcomes Res. 2012;12(1):71-94. PubMed PMID: 22280198.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A critical literature review of health economic evaluations in pertussis booster vaccination. AU - Millier,Aurelie, AU - Aballea,Samuel, AU - Annemans,Lieven, AU - Toumi,Mondher, AU - Quilici,Sibilia, PY - 2012/1/28/entrez PY - 2012/1/28/pubmed PY - 2012/5/15/medline SP - 71 EP - 94 JF - Expert review of pharmacoeconomics & outcomes research JO - Expert Rev Pharmacoecon Outcomes Res VL - 12 IS - 1 N2 - A review of worldwide economic evaluations of pertussis booster vaccination for adolescents and adults was conducted. Thirteen cost-effectiveness, cost-utility and economic impact models were identified. The most frequently studied strategies were adolescent booster, one-time adult booster, adult decennial boosters and cocoon strategy. All studies evaluating adolescent booster suggested this was a cost-effective or cost-saving strategy compared with no booster vaccination. Conclusions concerning adult vaccination, alone or in combination with adolescent vaccination, vary between studies. Studies were often strongly affected by assumptions regarding the amount of unreported cases and lack of reliable input data on real incidence, other epidemiological inputs, costs associated with mild disease and herd immunity effects. Reviewed studies were generally in favor of pertussis booster vaccination, but did not identify any optimal vaccination strategy. Future economic evaluations should explore a wider range of strategies, taking into account country-specific considerations. SN - 1744-8379 UR - https://www.unboundmedicine.com/medline/citation/22280198/A_critical_literature_review_of_health_economic_evaluations_in_pertussis_booster_vaccination_ L2 - https://www.tandfonline.com/doi/full/10.1586/erp.11.94 DB - PRIME DP - Unbound Medicine ER -